SEC Form 4 · accession 0001209191-16-152742
Adverum Biotechnologies, Inc. · ADVM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Woiwode
Director
Period of report
Nov 30, 2016
Accepted (ET)
Dec 1, 2016 · 6:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501756
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 30, 2016 | A | 3,509 | $0.00 | A | 31,054 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person is entitled to receive one (1) share of Common Stock of the Issuer for each one (1) restricted stock unit.